|
|
||||||||

Departments of 1 Urology and 2 Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112; 3 Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322; 4 Biomolecular Research Annex, University of Central Florida, Orlando, Florida 32816; and 5 Division of Cardiology, Department of Medicine, The Johns Hopkins Hospital, Baltimore, Maryland 21287
| |
ABSTRACT |
|---|
|
|
|---|
Increased superoxide anion
(O

gene therapy; aging; nitric oxide; erectile dysfunction
| |
INTRODUCTION |
|---|
|
|
|---|
MALE ERECTILE DYSFUNCTION (ED) has been defined as a persistent inability to maintain penile erection sufficient for normal sexual activity. Data from the Massachusetts Male Aging Study indicate that the prevalence of ED is 39% in 40-yr-old men and 67% in 70-yr-old men (18). Although the development of ED is multifactorial in nature, it is typically associated with vascular diseases and risk factors such as atherosclerosis, hypertension, diabetes mellitus, and cigarette smoking (4, 18, 35). Normal erectile function is defined by a delicate balance between vasoconstrictor and vasodilatory systems that determine the tone of corpora cavernosal smooth muscle of the penis. The nitric oxide (NO)/cGMP system is the principal mediator of penile erection and NO is synthesized by neuronal NO synthase (nNOS) and the endothelial isoform of NOS (eNOS) (4, 11, 40). Aging is recognized to alter endothelial cell function, and the decrease in age-related erectile function has been attributed to reductions in NOS activity, impaired endothelial-dependent smooth muscle relaxation, and diminished NO bioavailability (13, 26, 29).
Oxidative stress impairs vascular function. Superoxide anion
(O





| |
METHODS |
|---|
|
|
|---|
Adenovirus vectors.
Two replication-deficient recombinant adenoviruses (Ad) were used for
the gene transfer, both driven by a cytomegalovirus (CMV) promoter:
1) nuclear-targeted
-galactosidase (AdCMV
gal) and
2) extracellular SOD (AdCMVEC-SOD) were generated by
standard methods at the University of Iowa Gene Transfer Vector Core
Laboratory (37, 38). Human EC-SOD was cloned by blunt-end
ligation into plasmid (p)AdCMV4. The resultant plasmid and adenovirus
backbone sequences restricted of E1 were transfected into human
embryonic kidney-293 (HEK-293) cells, and plaques were isolated and
amplified for analysis of EC-SOD expression. Recombinant
adenoviruses were triple plaque purified to assure that viral
suspensions were free of wild-type virus, and virus titers were
determined by plaque assay on HEK-293 cells. After purification, the
virus was suspended in PBS with 3% sucrose and kept at
70°C until use.
Oxidative fluorescent microphotography.
Hydroethidine (Molecular Probes), an oxidative fluorescent dye, was
used to evaluate O


In vivo gene delivery to corpora cavernosa.
Four groups of rats were utilized in the following study: 1)
young rats (12 wk), 2) aged rats (80 wk) transfected with
AdCMV
gal, 3) aged rats (80 wk) transfected with
AdCMVEC-SOD, and 4) young rats (12 wk) transfected with
AdCMVEC-SOD. Twelve- and eighty-week-old male Brown Norway rats (young,
200-300 g; aged, 400-525 g) were purchased from the National
Institutes of Health (NIH)/National Institutes of Aging (NIA) colony
(Harlan Sprague-Dawley), maintained under controlled temperature and
lighting, and treated according to NIH regulations. Brown Norway rats
were chosen for this study because this species exhibits a combination
of primary and secondary testicular failure that more closely resembles
human reproductive aging and erectile function (27). The
aged rats were anesthetized with pentobarbital sodium (30 mg/kg ip) and
placed in a supine position on a temperature-regulated surgical table.
With the use of a sterile technique, the penis was exposed. Twenty
microliters of vehicle (3% sucrose in PBS), AdCMV
gal (1 × 108 parts/ml), or AdCMVEC-SOD (1 × 108
parts/ml) were injected into the corpus cavernosum with a 30-gauge needle attached to a microliter syringe, as previously described (3, 6, 14). Immediately before instillation, blood
drainage via the dorsal veins was halted by circumferential compression at the base of the penis with an elastic band. Compression was released
~2-5 min after injection of 20 µl of the vehicle/virus. Rats
did not show any overt signs of systemic (fever, dyspnea, and
tachycardia) or local (purulent discharge, erythema, and edema) infection when observed any day after transfection.
Detection of O

Expression of
-galactosidase in cavernosal tissue.
One to ten days after adenovirus administration of vehicle and
AdCMV
gal, the aged rats were euthanized with an overdose of pentobarbital sodium (80 mg/kg ip), and the penile shafts were removed.
Expression of
-galactosidase was evaluated by measurement of
-galactosidase activity in cavernosal tissue samples using a
-galactosidase reporter gene assay (Galacto-Light Plus Tropix; Bedford, MA) and X-Gal staining, as previously described (3, 6,
14). Briefly, corpus cavernosal tissue was minced into small
pieces with a scalpel and placed in lysis buffer for 15 min (75 µl
per sample; 0.2% Triton X-100 and 100 nmol potassium phosphate; pH
7.8). The samples were centrifuged (12,000 revolutions/min for 10 min),
and the supernatant was removed. Originals and dilutions (1:10 and
1:100) were prepared in duplicate for each tissue lysate. Aliquots of
tissue lysate were assayed for
-galactosidase activity with
3-(4-methoxyspiro{1,2-dioxetane-3,2'-tricyclo[3.3.13,7]decan}-4-yl)phenyl-
-D-galactopyraniside.
Light emission was measured with a luminometer (Luminoscan RS,
Labsystems) and calibrated with a standard curve generated with the use
of purified Escherichia coli
-galactosidase. Protein
concentrations of the samples were determined (Pierce Protein Assay,
Pierce Endogen), and normalized
-galactosidase activity was
expressed as relative light units of
-galactosidase per milligram of
protein. For histochemical analysis of
-galactosidase localization,
vehicle- and AdCMV
gal-transfected animals were euthanized, and the
penile shafts were cut in 2-mm saggital sections, which were then
incubated in X-Gal (Sigma) stain (PBS) composed of 20 mmol/l
K4Fe(CN)6 3H2O, 20 mmol/l K3Fe(CN)6, 2 mmol/l MgCl2,
and 1 mg/ml in DMSO of
5-bromo-4-chloro-3-indolyl-D-galactopyranoside for 24 h at room temperature, rinsed in PBS, and postfixed in 7% buffered
formalin for 6 h, overlaid with OCT compound, and frozen in liquid
nitrogen. Cryostat sections (30 µm) were mounted on
poly-L-lysine-coated slides and counterstained with eosin
Y. The penis sections were examined for positive
-galactosidase staining (blue nuclei) by light microscopy.
Western blot analysis of EC-SOD.
Expression of EC-SOD and
-actin in aged rat cavernosal tissue was
assessed one day after intracavernosal injection of AdCMV
gal and
AdCMVEC-SOD and a younger cohort of animals. The supernatant was
mixed with an equal volume of 2% SDS-1%
-mercaptoethanol and
fractionated using 8% SDS-PAGE (70 µg/lane). Proteins were transferred to a nitrocellulose membrane (Hybond-ECL, Amersham Life
Sciences) by semidry electroblotting. The membranes were blocked 1 h at room temperature with blotto-Tween (5% nonfat dry milk and 0.1%
Tween 20) and incubated with a primary monoclonal rabbit anti-EC-SOD
(1:5,000; Johns Hopkins Hospital) and primary monoclonal rabbit
anti-
-actin (1:10,000; Santa Cruz Biotechnology). Bound antibody was
detected with labeled goat anti-rabbit IgG secondary antibody
(1:20,000; Santa Cruz Biotechnology) and visualized with enhanced
chemiluminescence. The Western blot technique for determination of
EC-SOD has been described earlier (19, 25).
Northern blot analysis of EC-SOD.
Total RNA was isolated from cavernosal tissue of young rats and aged
rats transfected with AdCMV
gal and AdCMVEC-SOD using Tri-reagent
(Molecular Research Center), as previously described (5,
6). For Northern blot analysis, 20 µg of total RNA from each
sample were separated on 1% formaldehyde agarose gels. Identical loading of the gel lanes was confirmed by comparing the EtBr staining of the GAPDH bands. Blotting, cross linking, and hybridization were
performed with cDNA for EC-SOD, as previously described
(9).
Immunohistochemical localization of nitrotyrosine.
Immunohistochemical localization of nitrotyrosine was performed in the
penises of young rats and one day after transfection with AdCMV
gal
and AdCMVEC-SOD in the aged rat. The penile shaft was separated from
the crura, cut in cross sections, fixed in 10% formalin, and paraffin
embedded. Endogenous peroxidases were quenched with 3%
H2O2, and sections were washed with PBS.
Nonspecific binding of IgG was blocked using normal horse serum, 1:50
of 0.1% bovine serum albumin in PBS. The sections were incubated with a rabbit monoclonal antibody for antinitrotyrosine (1:3,000; Upstate Biotechnology), washed, and then incubated for an additional 30 min
with a biotinylated secondary antibody. After a 30-min incubation with
ABC horseradish peroxidase (DAKO), the substrate (DAB, Vectastain, Vector Laboratories) was added for 5 min. This resulted in positive cells labeled brown. Sections were then stained with hematoxylin. All
histological sections stained for nitrotyrosine were examined by three
independent observers and given a grade to determine the extent of
expression in the cavernosal tissue of the rats, as described
previously (3, 5).
Measurement of cavernosal tissue cGMP levels.
Cavernosal cGMP levels were measured in young rats and 1 day after
instillation of AdCMV
gal and AdCMVEC-SOD into the corpus cavernosum
of aged rats. Whole corpus cavernosum tissue was homogenized in 1 ml
ice-cold 6% trichloroacetic acid (TCA), pH 4.0, and centrifuged at
1,500 g for 10 min at 4°C, and the supernatant was
transferred to a 10-ml test tube. The TCA was extracted with
H2O saturated diethyl ether. The samples were assayed for
cGMP with an enzyme immunoassay kit (Cayman Chemical), as described
earlier (7, 14).
Measurement of erectile responses. Twelve-week-old Brown Norway rats were anesthetized with pentobarbital sodium (30 mg/kg ip) and placed on a temperature-regulated surgical table. One day after vehicle or adenovirus administration, 80-wk-old Brown Norway rats were anesthetized with pentobarbital sodium (30 mg/kg ip) and placed on a thermo-regulated surgical table. The trachea was cannulated [polyethylene (PE)-240 tubing] to maintain a patent airway, and the animals breathed room air enriched with 95% O2-5% CO2. A carotid artery was cannulated (PE-50 tubing) for the measurement of systemic arterial pressure. Systemic arterial pressure was measured continuously with a Statham P23 transducer attached to a computerized system for data acquisition (DATAQ, Data Systems International). The left jugular vein was cannulated with PE-50 tubing for the administration of fluids and supplemental anesthesia.
The bladder and prostate were exposed through a midline abdominal incision. The prostatic ganglion and cavernosal nerve were identified posterolateral to the prostate on one side, and an electrical stimulator with a stainless steel bipolar hook was placed around the cavernosal nerve. A 25-gauge needle filled with heparin (250 U/ml) and connected to PE-50 tubing was inserted into the right crura. Systemic arterial and intracavernosal pressures were measured with Statham P23 pressure transducers connected to a computerized system for data acquisition (DATAQ; Data Systems International). The cavernosal nerve was stimulated with a square wave stimulator (Grass Instruments). Each rat underwent electrical field stimulation at a frequency of 15 Hz, pulse width 30 s, and duration of ~1 min. A stimulus intensity of 2.5, 5, and 7.5 V was used in the current protocol to achieve a significant consistent stimulus-dependent erectile response. These procedures have been previously described (6, 15, 17). The Tulane University School of Medicine Animal Care and Use Committee approved all of the procedures used in the present study. In experiments in which ACh (Sigma), an endothelium-dependent vasodilator, and zaprinast (Sigma), a specific type 5 phosphodiesterase (PDE5) inhibitor (both diluted to a consistent volume of 50 µl) were utilized, and intracavernosal administration via a 30-gauge needle inserted into the left corpus cavernosum was performed, as described previously (14). In all experiments, injections of agonists were made when cavernosal pressure was at baseline value. The erectile effects of a single injection of ACh (10 and 30 µg/ml) and zaprinast (30 and 100 µg/ml) on intracavernosal pressure were monitored until intracavernosal pressure returned to the preinjection level. The next injection was made after a 10- to 15-min period from the end of the preceding response to ensure a stable baseline. Injection of 50 µl of the saline vehicle had no significant effect on intracavernosal pressure.Statistical analysis. The data are expressed as means ± SE and were analyzed using a one-way analysis of variance with repeated measures and Newman-Keuls post hoc test for multiple group comparisons (Statview, Abacus Concepts). A P value of <0.05 was used as the criterion for statistical significance.
| |
RESULTS |
|---|
|
|
|---|
Confocal microscopic examination of
O


|
Cavernosal superoxide levels and SOD activity.
To quantify O



gal (Fig. 2D). Cavernosal
tissue from aged rats transfected with AdCMVEC-SOD showed an
approximate fivefold increase in SOD activity compared with
activity in the other groups (Fig. 2D).
|
-Galactosidase activity in cavernosal tissue.
One day after intracavernosal administration of vehicle or
AdCMV
gal,
-galactosidase localization was determined by light microscopy (Fig. 3A). The time
course and magnitude of
-galactosidase activity using
chemiluminescence is shown in Fig. 3B. Cavernosal tissue
from aged rats transfected with vehicle showed minimal
-galactosidase expression, whereas cavernosal tissue of
AdCMV
gal-transfected aged rats had significantly higher
-galactosidase expression and quantitated activity (Fig.
3B).
-Galactosidase activity was similar in the vehicle
and AdCMVEC-SOD-transfected aged rats (data not shown). Expression of
-galactosidase peaked 1 day after transfection with AdCMV
gal and
remained at peak levels for 3-5 days at which time expression
began to decay to baseline levels, such that at 14 days
posttransfection, there was no measurable expression of
-galactosidase (Fig. 3B).
|
Western blot analysis of EC-SOD.
EC-SOD protein levels were measured in cavernosal tissue of both young
and aged rats 1 day after intracavernosal administration of AdCMV
gal
and AdCMVEC-SOD, and these data are summarized in Fig.
4A. Cavernosal EC-SOD protein
levels were not significantly different in the aged rats (lane
2, Fig. 4A) compared with levels in young rats
(lane 1, Fig. 4A). One day after transfection
with AdCMVEC-SOD, EC-SOD protein levels (32 kDa) in cavernosal tissue were significantly higher in aged rats (lane 3, Fig.
4A) compared with levels in aged rats transfected with
AdCMV
gal (lane 2; Fig. 4A). When EC-SOD levels
were analyzed by densitometry and expressed per milligram of protein,
EC-SOD protein levels were significantly higher in aged rats after
transfection with AdCMVEC-SOD compared with EC-SOD protein levels in
aged rats treated with AdCMV
gal and when compared with EC-SOD levels
in young animals (Fig. 4A).
|
Northern blot analysis of EC-SOD.
EC-SOD RNA levels were measured in cavernosal tissue of young rats and
1 day after intracavernosal administration of AdCMV
gal and
AdCMVEC-SOD in aged rats. These data are summarized in Fig. 4B. Cavernosal EC-SOD RNA levels were not significantly
different in aged rats transfected with AdCMV
gal (lane 2,
Fig. 4B) compared with the young rats (lane 1,
Fig. 4B). One day after transfection with AdCMVEC-SOD,
EC-SOD RNA levels in cavernosal tissue were significantly higher
(lane 3, Fig. 4B) when compared with levels in
aged rats transfected with AdCMV
gal (lane 2, Fig.
4B). When EC-SOD levels were analyzed by densitometry and
expressed as a ratio of SOD signal divided by GAPDH signal, EC-SOD
levels were significantly higher in aged rats after transfection with
AdCMVEC-SOD compared with EC-SOD RNA levels in aged rats treated with
AdCMV
gal and compared with EC-SOD levels in the young animals (Fig.
4B).
Cavernosal cGMP levels.
Cavernosal tissue cGMP concentrations were measured in young and in
aged rats treated with vehicle, AdCMV
gal, and AdCMVEC-SOD, and these
data are summarized in Fig. 5. Cavernosal
cGMP levels were significantly lower in the aged rats compared with
levels in young rats (Fig. 5). Gene transfer of EC-SOD in the aged rat penis resulted in cavernosal cGMP concentrations that were
significantly higher compared with cGMP levels in aged rats transfected
with AdCMV
gal (Fig. 5). There was an approximate twofold increase in
cGMP levels in cavernosal tissue from animals transfected with AdCMVEC-SOD that was similar to levels found in younger rats. cGMP
levels were similar in aged rat cavernosal tissue transfected with
vehicle and with AdCMV
gal (data not shown).
|
Immunohistochemical localization of nitrotyrosine.
To measure the expression of nitrotyrosine, a specific marker of
peroxynitrite formation, in young and aged rats after adenoviral transfection of the penis, immunohistochemical localization of nitrotyrosine was performed 1 day after transfection with AdCMV
gal and AdCMVEC-SOD and these data are summarized in Fig.
6. Immunohistochemical staining of
nitrotyrosine was markedly higher in the endothelium and cavernosal
smooth muscle of aged rats transfected with AdCMV
gal compared with
the staining in young rats (Fig. 6). There was no difference in penile
nitrotyrosine staining in aged animals transfected with AdCMV
gal and
vehicle (data not shown). However, animals receiving intracavernosal
injection of AdCMVEC-SOD had lower nitrotyrosine expression in the
endothelium and smooth muscle of the corpus cavernosum, suggesting that
EC-SOD gene transfer reduced peroxynitrite formation (Fig. 6).
|
Influence of age on erectile response in rat.
The effect of cavernosal nerve stimulation and intracavernous injection
of ACh on erectile function in vivo was determined in three separate
ages (12, 80, and 110 wk) of Brown Norway rats. There was an
age-dependent decrease (P < 0.05) in erectile function to both cavernosal nerve stimulation and intracavernous injection of
ACh (Fig. 7).
|
Effect of AdCMVEC-SOD on erectile responses in aged rat.
The effect of cavernosal nerve stimulation and pharmacological agents
on erectile function in vivo was measured to evaluate the physiological
consequence of overexpression of the EC-SOD gene transferred to the
corpus cavernosum of aged rats. There was a significantly lower
voltage-dependent cavernosal nerve-induced erectile response in aged
animals when compared with responses in younger rats (Fig.
8). The magnitude of the increase in
cavernosal pressure in response to cavernosal nerve stimulation in aged
rats transfected with AdCMV
gal was significantly lower than the
younger rats, whereas rats transfected with the gene encoding EC-SOD
had a larger response to cavernosal nerve stimulation that was similar to the response obtained in young rats (Fig. 8A). The
magnitude of erectile responses to cavernosal nerve stimulation in
vehicle-treated aged rats and those treated with AdCMV
gal was
similar (data not shown). The increase in cavernosal pressure in the
AdCMVEC-SOD-transfected group was similar to the response in younger
control rats at all voltage settings (2.5, 5, and 7.5) (Fig.
8B). Responses were reproducible 30 min after the initial
stimulation (data not shown).
|
gal compared with responses in the
young rats (Fig. 9). Increases in cavernosal pressure were similar in
animals transfected with vehicle and AdCMV
gal (data not shown). In
aged rats transfected with AdCMVEC-SOD the increase in cavernosal
pressure in response to intracavernosal injections of ACh (10 and 30 µg/ml) and zaprinast (30 and 100 µg/ml) were significantly greater
in magnitude than responses in aged rats treated with AdCMV
gal and
were similar to responses seen in younger animals (Fig. 9).
|
Effect of AdCMVEC-SOD on erectile responses in young rat.
The effect of overexpression of EC-SOD in the corpus cavernosum
of young rats was investigated to determine whether EC-SOD transfection
had a specific effect on diminished erectile responses in aged rats or
if it enhanced normal erectile function in young rats. One day after
AdCMVEC-SOD transfection to the young rat, no change in erectile
function, as determined by cavernosal nerve stimulation and
intracavernosal administration of ACh, was observed compared with
responses in age-matched control animals (Fig.
10).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The results of the present study demonstrate an increase in
O



The process of biological aging is multifactorial in nature and is
dependent on several factors, including but not limited to, metabolic
rate, genetics, lifestyle, and environmental issues (41).
The concept that free radical damage plays a role in mediating degenerative changes of aging was originally postulated by Harman (31) in 1956, in which it was hypothesized that
progressive aging is associated with increased amounts of oxidatively
modified biomolecules resulting from free radical reactions. Since the development of this theory, several lines of evidence provide support
for the concept that free radical damage is an important component of
the aging process. More recently, oxidative damage to the vasculature
has been postulated to be a caused by O


As men age, a reduction in libido and a significant decline in erectile
function occur. The constitutive forms of NOS, eNOS and nNOS, are the
principal mediators of cavernosal smooth muscle relaxation (10,
32). Most experts believe this reduction in erectile function
can be attributed to endogenous decreases in the formation of NO in the
corpus cavernosum. We (6, 14) have shown that
overexpression of eNOS by adenoviral gene transfer to the penis of aged
rats restores erectile function, suggesting that decreased production
or bioavailability of NO and a resulting reduction in cGMP formation in
the penis play a significant role in mediating age-associated erectile
dysfunction. O






O


Superoxide radical production is increased in the cavernosal tissue of
hypercholesterolemic rabbits and leads to a functional impairment of
endothelium-dependent cavernosal smooth muscle relaxation in vitro
(34). Additionally, NO-mediated cavernosal smooth muscle relaxation is impaired in organ bath studies using diabetic rabbit cavernosal tissue; an effect that was reversed with SOD treatment (33). These data provide evidence that in certain disease,
such as hypercholesterolemia and diabetes, superoxide radicals are increased, possibly by the upregulation of NADPH oxidase. Collectively, these studies document a potential role for superoxide radicals in the
pathophysiology of male ED. Our results support previous studies by
providing evidence that overexpression of O


ACh interacts with muscarinic receptors on the cavernosal endothelium to primarily release NO, and the results of the present study show that with aging, the erectile response to ACh is reduced. This reduction may be multifactorial in nature and may reflect changes in NOS expression, availability of NO substrate, the scavenging of NO, or changes in guanylate cyclase activity and downstream mechanisms. Our results may be interpreted to suggest that bioavailability of NO, once released, may be an important factor in aging because transfection with EC-SOD resulted in erectile responses that were similar to those observed in young animals. Alternatively, because tyrosine nitrosylation is markedly reduced by AdCMVEC-SOD, the beneficial effect of EC-SOD transfection may result from a reduction in effector system function caused by peroxynitrite. Similar reductions in response to the PDE5 inhibitor zaprinast were observed in aged animals and may reflect alterations in enzyme activity caused by tyrosine nitrosylation. Alternatively, because cGMP levels were reduced in aged rats, the inhibition of PDE5 was not optimal because the enzyme did not have sufficient substrate, and inhibition of the enzyme did not increase cGMP levels high enough to induce significant erectile responses in the aged rat.
Sildenafil citrate (Viagra), a selective PDE5 inhbitor, inhibits the hydrolysis of cGMP in the corpus cavernosum, thereby increasing cavernosal smooth muscle relaxation and prolonging penile erection (8). Despite the general overall success of oral agents, such as sildenafil citrate, there are still patients who do not respond to this pharmacological agent. Therefore, there are still cases of incomplete response. There are also side effects and contraindications for the use of oral PDE5 inhibitors for the treatment of ED. Gene therapy for ED offers a distinct advantage in that the anatomy of the penis and its own external circulation, allows a gene to be transferred and localized in the organ and thereby lessening the risk of systemic side effects (16). By identifying specific genes crucial to normal erectile physiology, a specific gene therapy approach may be useful for the treatment of erectile dysfunction.
In conclusion, the enhanced generation of O

| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Janice Ignarro for help in the preparation of this manuscript and Drs. Donald Heistad and Beverley Davidson and the University of Iowa Vector Core Laboratory for preparation of the adenoviral vectors.
| |
FOOTNOTES |
|---|
This work was supported in part by a Young Investigator Award from the International Society of Impotence Research and Pfizer (to T. J. Bivalacqua and H. C. Champion), Southern Medical Association (to T. J. Bivalacqua), the American Federation for Aging Research (to T. J. Bivalacqua), the Shin Chun-Wang Award from the American Physiological Society (to H. C. Champion), and by National Heart, Lung, and Blood Institute Grants HL-62000 (to P. J. Kadowitz) and HL-0494 (to H. C. Champion).
Address for reprint requests and other correspondence: H. C. Champion, Div. of Cardiology, Dept. of Medicine, The Johns Hopkins Hospital, 600 North Wolfe St., Carnegie 568, Baltimore, MD 21287 (E-mail: hchampi{at}jhmi.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published December 27, 2002;10.1152/ajpheart.00770.2002
Received 11 September 2002; accepted in final form 23 December 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abete, P,
Napoli C,
Santoro G,
Ferrara N,
Tritto I,
Chiariello M,
Rengo F,
and
Ambrosio G.
Age-related decrease in cardiac tolerance to oxidative stress.
J Mol Cell Cardiol
31:
227-236,
1999[ISI][Medline].
2.
Ames, BN,
Shigenaga MK,
and
Hagen M.
Oxidants, antioxidants, and the degenerative diseases of aging.
Proc Natl Acad Sci USA
90:
7915-7922,
1993
3.
Bivalacqua, TJ,
Champion HC,
Abdel-Mageed AB,
Kadowitz PJ,
and
Hellstrom WJ.
Gene transfer of preprocalcitonin gene related peptide restores erectile function in the aged rat.
Biol Reprod
65:
1371-1377,
2001
4.
Bivalacqua, TJ,
Champion HC,
Hellstrom WJ,
and
Kadowitz PJ.
Pharmacotherapy for erectile dysfunction.
Trends Pharmacol Sci
21:
484-489,
2000[Medline].
5.
Bivalacqua, TJ,
Champion HC,
Leungwattanakij S,
Yang DY,
Hyun JS,
Abdel-Mageed AB,
Sikka SC,
Kadowitz PJ,
and
Hellstrom WJ.
Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat.
J Androl
22:
497-506,
2001[Abstract].
6.
Bivalacqua, TJ,
Champion HC,
Mehta YS,
Abdel-Mageed AB,
Sikka SC,
Ignarro LJ,
Kadowitz PJ,
and
Hellstrom WJ.
Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat.
Int J Impot Res
3:
S8-S17,
2000.
7.
Bivalacqua, TJ,
Diner EK,
Novak TE,
Vohra Y,
Sikka SC,
Champion HC,
Kadowitz PJ,
and
Hellstrom WJ.
A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression.
J Urol
163:
1992-1998,
2000[ISI][Medline].
8.
Boolell, M,
Allen MJ,
Ballard SA,
Gepi-Atatee S,
Muirhead GJ,
Naylor AM,
Osterloh IH,
and
Gingell C.
Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
Int J Impot Res
8:
47-52,
1996[Medline].
9.
Brandes, RP,
Koddenberg G,
Gwinner W,
Kim D,
Kruse HJ,
Busse R,
and
Mugge A.
Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia.
Hypertension
33:
1243-1249,
1999
10.
Burnett, AL.
Role of nitric oxide in the physiology of erection.
Biol Reprod
52:
485-489,
1995[Abstract].
11.
Burnett, AL,
Lowenstein CJ,
Bredt DS,
Chang TS,
and
Snyder SH.
Nitric oxide: a physiologic mediator of penile erection.
Science
257:
401-403,
1992
12.
Cai, H,
and
Harrison DG.
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.
Circ Res
87:
840-844,
2000
13.
Carrier, S,
Nagaraju P,
Morgan DM,
Baba K,
Nunes L,
and
Lue TF.
Age decreases nitric oxide synthase-containing nerve fibers in the rat penis.
J Urol
157:
1088-1092,
1997[ISI][Medline].
14.
Champion, HC,
Bivalacqua TJ,
Hyman AL,
Ignarro LJ,
Hellstrom WJ,
and
Kadowitz PJ.
Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat.
Proc Natl Acad Sci USA
96:
11648-11652,
1999
15.
Chitaley, K,
Wingard CJ,
Clinton Webb R,
Branam H,
Stopper VS,
Lewis RW,
and
Mills TM.
Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway.
Nat Med
7:
119-122,
2001[ISI][Medline].
16.
Christ, GJ,
and
Melman A.
The application of gene therapy to the treatment of erectile dysfunction.
Int J Impot Res
10:
111-112,
1998[ISI][Medline].
17.
Christ, G,
Rehman J,
Day N,
Salkoff L,
Valcic M,
Melman A,
and
Geliebter J.
Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function.
Am J Physiol Heart Circ Physiol
275:
H600-H608,
1998
18.
Feldman, HA,
Goldstein I,
Hatzichristou DG,
Krane RJ,
and
McKinlay JB.
Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.
J Urol
151:
54-61,
1994[ISI][Medline].
19.
Fennell, JP,
Brosnan MJ,
Frater AJ,
Hamilton CA,
Alexander MY,
Nicklin SA,
Heistad DD,
Baker AH,
and
Dominiczak AF.
Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension.
Gene Ther
9:
110-117,
2002[ISI][Medline].
20.
Ferrara, N,
Abete P,
Ambrosio G,
Landino P,
Caccese P,
Cirillo P,
Oradei A,
Littarru GP,
Chiariello M,
and
Rengo F.
Protective role of chronic ubiquinone administration on acute cardiac oxidative stress.
J Pharmacol Exp Ther
274:
858-865,
1995
21.
Ferrini, M,
Magee TR,
Vernet D,
Rajfer J,
and
Gonzalez-Cadavid NF.
Aging-related expression of inducible nitric oxide synthase and markers of tissue damage in the rat penis.
Biol Reprod
64:
974-982,
2001
22.
Fridovich, I.
Superoxide radical and superoxide dismutases.
Annu Rev Biochem
64:
97-112,
1995[ISI][Medline].
23.
Fridovich, I.
Superoxide anion radical (O
24.
Fukai, T,
Galis ZS,
Meng XP,
Parthasarathy S,
and
Harrison DG.
Vascular expression of extracellular superoxide dismutase in atherosclerosis.
J Clin Invest
101:
2101-2111,
1998[ISI][Medline].
25.
Fukai, T,
Siegfried MR,
Ushio-Fukai M,
Griendling KK,
and
Harrison DG.
Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension.
Circ Res
85:
23-28,
1999
26.
Garban, H,
Vernet D,
Freedman A,
Rajfer J,
and
Gonzalez-Cadavid N.
Effect of aging on nitric oxide-mediated penile erection in rats.
Am J Physiol Heart Circ Physiol
268:
H467-H475,
1995
27.
Greuenewald, DA,
Naai MA,
Hess DL,
and
Matsumoto AM.
The brown Norway rat as a model of reproductive aging: evidence for both primary and secondary testicular failure.
J Gerontol B Psychol Sci Soc Sci
49:
B42-B50,
1994.
28.
Gupte, S,
Rupawalla T,
Mohazzab HK,
and
Wolin M.
Regulation of NO-elicited pulmonary artery relaxation and guanylate cyclase activation by NADH oxidase and SOD.
Am J Physiol Heart Circ Physiol
276:
H1535-H1542,
1999
29.
Haas, C,
Seftel AD,
Razmjouei K,
Ganz MB,
Hampel N,
and
Ferguson K.
Erectile dysfunction in aging: upregulation of endothelial nitric oxide synthase.
Urology
51:
5160522,
1998.
30.
Hamilton, CA,
Brosnan MJ,
McIntyre M,
Graham D,
and
Dominiczak AF.
Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction.
Hypertension
37:
529-534,
2001
31.
Harman, D.
Aging: a theory based on free radical and radiation chemistry.
J Gerontol
11:
298-300,
1956[ISI][Medline].
32.
Ignarro, LJ,
Bush PA,
Buga GM,
Wood KS,
Fukuto JM,
and
Rajfer J.
Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle.
Biochem Biophys Res Commun
170:
843-850,
1990[ISI]